Net profit of Fermenta Biotech reported to Rs 9.85 crore in the quarter ended December 2023 as against net loss of Rs 37.39 crore during the previous quarter ended December 2022. Sales rose 80.40% to Rs 98.97 crore in the quarter ended December 2023 as against Rs 54.86 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales98.9754.86 80 OPM %25.38-17.90 - PBDT22.46-14.96 LP PBT16.07-21.29 LP NP9.85-37.39 LP Powered by Capital Market - Live News

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net Loss of Fermenta Biotech reported to Rs 27.80 crore in the quarter ended September 2023 as against net loss of Rs 8.09 crore during the previous quarter ended September 2022. Sales declined 41.95% to Rs 56.91 crore in the quarter ended September 2023 as against Rs 98.03 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales56.9198.03 -42 OPM %-24.463.35 - PBDT-15.701.11 PL PBT-21.64-7.96 -172 NP-27.80-8.09 -244 Powered by Capital Market - Live News

Net loss of Fermenta Biotech reported to Rs 27.98 crore in the quarter ended September 2023 as against net profit of Rs 2.12 crore during the previous quarter ended September 2022. Sales declined 43.06% to Rs 51.31 crore in the quarter ended September 2023 as against Rs 90.12 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales51.3190.12 -43 OPM %-22.6312.44 - PBDT-13.308.94 PL PBT-18.982.69 PL NP-27.982.12 PL Powered by Capital Market - Live News

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News